Company / Tangible Book Value per Share
BridgeBio Pharma, Inc. Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$10.98
FY2025
5-year range
-$10.98 / -$7.09
FY2021-FY2025
Trend
-31.0%
vs FY2024
Sector context
#205 of 209
Health Care
What the data says
Among 209 Health Care companies, BridgeBio Pharma, Inc. is in the bottom 2% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 9 years, ranging from $-10.98 in FY2025 to $6.11 in FY2018.
Based on SEC 10-K filings.
-10.98 in FY2025.
Declined from $-8.99 to $-10.98 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 209This company -$10.98 Sector average $119.74
▼
-109.2% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 31.0% year-over-year.
- Ranks #205 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.98 | -31.0% |
| FY2024 | -$8.38 | +6.7% |
| FY2023 | -$8.99 | -5.6% |
| FY2022 | -$8.51 | -20.2% |
| FY2021 | -$7.09 | -1613.0% |
| FY2020 | $0.47 | -89.4% |
| FY2019 | $4.44 | -27.4% |
| FY2018 | $6.11 | +111.5% |
| FY2017 | $2.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026